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Thyroid hormones enhance aerobic metabolism favoring
oxidative stress which may lead to covalent damage of various
molecules including DNA. Previous investigations revealed that thyroid
hormones induce DNA damage on human lymphocytes and sperm in
the in vitro Comet assay. However, cytogenetic evaluation of genotoxic
effects of thyroxine gave equivocal results: increase of sister chromatid
exchanges, and no incerase of micronuclei in cultured human
lymphocytes. Therefore, the aim of the present study was to further
evaluate the possible genotoxic effects of thyroxine using in vivo
cytogenetic test on Swiss albino mice.
Three experimental concentrations of thyroxine were used
(0.1 mg/kg, 0.5 mg/kg and 2.5 mg/kg). The mice were divided into
several groups depending on the duration of the treatment with
thyroxine. Thus, we treated mice for 1, 3, 7 and 10 days. Positive (N-
methyl-N'-nitro-N-nitrosoguanidine) and negative controls were also
formed for the same time periods. Cytogenetic endpoinds (numerical
and structural aberrations, chormosome gaps and breaks) were
analysed in bone marrow cells from femures.
The results obtained in this investigation showed that thyroxine
has not induced chromosome damage or aberrations. This is in
agreement with our previous analysis of micronuclei in human
peripheral blood lymophocytes treated with thyroxine. On the other
hand, we observed a decrease of mitotic index especially in animals
treated for a longer period of time with the highest dose of thyroxine.
Therefore, it can be concluded that thyroxine does not induce
genotoxic effects which could be detected by cytogenetic analysis.
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INTRODUCTION
Thyroid hormones play essential roles in the processes of metabolism,
growth and development in most vertebrate tissues (Lazar, 2003). Although there
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are abundant literature data concerning the molecular mechanisms of thyroid
hormone action in various biochemical and physiological processes (Goglia et al.,
1999), little is known about the possible genotoxic and mutagenic effects of
thyroid hormones and/or their metabolites.
However, it is well established that thyroid hormones increase aerobic
metabolism in mitochondria which causes intense production of reactive oxygen
and nitrogen species, leading to the condition of oxidative stress (Venditti et al.,
2003; Fernandez et al., 2005). In addition, binding of thyroid hormone to specific
nuclear receptors in target cells induces enzymes related to redox processes and
the total rate of oxygen consumption is enhanced (Oppenheimer et al., 1996).
Reactive oxygen species (ROS) induced by thyroid hormones may cause lipid
and protein oxidation in rat hepatocytes (Tapia et al., 1999). Moreover,
experimentally induced hyperthyroidism is accompanied by an increased rate of
O2 consumption and enhanced microsomal oxidative capacity and generation of
ROS in the rat liver (Fernandez et al., 2003). Interestingly, creation of oxidative
stress is even more potentated by thyroid hormone-induced decrease of
superoxide dismutase (SOD) and catalase activities, as well as by the reduced
glutathione content in the liver cells (Fernandez et al., 1988). This depression of
key antioxidative mechanisms favors oxidative stress in the liver (Tapia et al.,
1999).
Overwhelming evidence indicates that oxidative stress can lead to DNA
damage and mutations (Sakai et al., 2006; Lankoff et al., 2006). Indeed, there are
some indices that thyroid hormones can induce oxidative stress accompanied by
DNA damage in human lymphocytes (Djeli} and Anderson, 2003) and sperm
(Dobrzynska et al., 2004) evaluated by the Comet assay in vitro. On the other
hand, thyroxine exhibited only weak clastogenic effects expressed as an
increased sister chromatid exchange, without a significant increase in
micronucleus frequencies in cultured human peripheral blood lymphocytes
(Djeli} et al., 2006). It should be noted, however, that these equivocal data were
obtained using whole blood cultures, whereas DNA damage in the Comet assay
was observed on purified human lymphocytes. Namely, it is possible that
enzymes catalase and gluthathione peroxidase which are normally present in
erytrocytes in whole blood cultures can reduce the effects of reactive oxygen
species (Andreoli et al., 1999) which may be produced under the influence of
thyroid hormones.
Since the evaluation of cytogenetic effects of thyroxine in cultured human
lymphocytes was equivocal, in the present study we aimed to investigate the
possible cytogenetic changes in bone marrow cells of Swiss albino mice, after
acute or subacute exposure to L-thyroxine. Therefore, this investigation should
further elucidate the possbile clastogenic and/or aneugenic effects of thyroid
hormones. It is particularly interesting that the effects of thyroid hormones were
monitored on cells exposed in vivo.
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MATERIALS AND METHODS
Test substance and controls. The test substance used for the evaluation of
the possible genotoxic effects was L-thyroxine (CAS No 51-48-9, Sigma Chemical
Co., St. Louis, MO, USA) dissolved in 0.1 M NaOH. The solvent was used as a
negative control, whereas the well known mutagen N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG, CAS No 70-25-7, Sigma Chemical Co., St. Louis, MO,
USA) dissolved in dimethylsulfoxide (DMSO) was chosen as the positive control.
Animals. In this investigation we used Swiss albino mice from the Institute of
immunobiology and virusology „Torlak“ (Belgrade). All animals were acclimatized
for 7 days prior to the start of the experiments. Animals were kept under standard
conditions: room temperature (21±1)oC, humidity 55-60%, food and water ad
libitum, standard daily illumination. For each experimental and control group 4
males weighting 20-25 g were used.
In vivo cytogenetic test. Animals were divided into several groups: negative
control (solvent-treated), positive control (treated with the well known mutagen
MNNG) and thyroid hormone-treated animals. Three doses of T4 (0.1 mg/kg,
0.5 mg/kg and 2.5 mg/kg were used. Animals were treated with intraperitoneal T4
injection for 1, 3 and 7 and 10 days. After the last treatment, after 24 h, the animals
were treated with colchicine (Sigma chemical Co., St. Louis, MO, USA, final
concentration 4mg/kg) in order to cause metaphase arrest. Two hours after the
treatment the femures in ether anesthesia were removed. Chromosome
preparations were made according to the method of Evans and O'Riordan (1975)
as previously described in detail (Djeli} et al., 1996). Bone marrow was isolated in
0.9% w/v NaCl. After centrifugation cell pellets were treated with hypotonic
solution (0.075M KCl) for 20 min at 37oC. Afterwards, three repetitive cycles of
fixation in methanol-acetic acid (3:1, v/v) were performed. After the last fixation we
resuspended the cell pellet in 0.5 mL of supernatant to which one drop of 60%
CH3COOH was added. Finally, a few drops of cell pellet were air dried and stained
with 5% Giemsa (Merck, Darmstadt, Germany). In order to determine the mitotic
index at least 1000 cells per experimental animal were scored, and for
chromosome lesions and aberrations 100 metaphase spreads per animal were
analysed.
Statistical analysis. The statistical analysis of cytogenetic endpoints was
performed by 2 test using the Statgraph 4.2 software. Mitotic indices were
analysed by z-test. A P-value of  0.05 was considered as indicative of statistical
significance for all tests used.
RESULTS
Results of the mitotic indices in thyroxine-treated animals and controls are
presented in Table 1. Evidently, mitotic index is not significantly changed at all
doses of thyroxine following the 24 h treatment. Treatment for 3 days caused a
significant decrease (P<0.01) in mitotic index only at the highest experimental
concentration (2.5 mg/kg). Likewise, after 7 and 10 days of treatment only the
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highest concentration of thyroxine significantly (P<0.001) decreased MI. As
expected, the positive control (10–6 M MNNG) caused a significant decrease of MI
at all time periods. However, the suppresion of mitotic activity caused by MNNG
was more profound at longer periods of treatment with thyroxine.
Table 1. Mitotic indices of Swiss albino mice treated with thyroxine for 1, 3, 7 and 10
days
Treatment No of analysedcells
MI (%)
(min-max) Mean MI±S.D. (%)
Negative control, 24 h 4536 4.15-6.11 5.13±0.71
0.1 mg/kg, 24 h 4008 5.21- 5.71 5.47±0.18
0.5 mg/kg, 24 h 4014 4.13-6.04 5.34±0.72
2.5 mg/kg, 24 h 4055 4.05-4.81 4.61±0.32
Positive control, 24 h 4427 1.94-2.44 2.04±0.22***
Negative control, 3 days 4001 5.10-6.52 5.81±0.50
0.1 mg/kg, 3 days 4507 4.27-5.81 4.89±0.63
0.5 mg/kg, 3 days 4088 5.06-6.45 5.60±0.61a
2.5 mg/kg, 3 days 4021 3.02-3.96 3.63±0.36**
Positive control, 3 days 4092 1.13-1.98 1.58±0.32***
Negative control, 7 days 4613 3.78-6.36 5.37±0.96
0.1 mg/kg, 7 days 4079 4.86-6.07 5.40±0.50b
0.5 mg/kg, 7 days 4150 4.14-5.66 4.98±0.62
2.5 mg/kg, 7 days 4003 2.85-3.84 3.41±0.36***
Positive control, 7 days 4224 1.08-1.77 1.41±0.26***
Negative control, 10 days 4028 4.55-5.92 5.27±0.51
0.1 mg/kg, 10 days 4201 4.19-5.10 4.83±0.34
0.5 mg/kg, 10 days 4096 4.24-5.20 4.46±0.34
2.5 mg/kg, 10 days 4074 2.38-3.27 2.82±0.44***c
Positive control, 10 days 4030 0.94-1.87 1.28±0.46***d
MI – mitotic index, S.D. – standard deviation; **P<0.01; ***P<0.001 (z-test)
a) one animal died on the 3rd day of treatment
b) one animal died on the 2nd day of treatment
c) one animal died on the 6th day, and one animal died on 9th day of treatment
d) two mice died on 8th and 9th day of treatment, respectively
As for chromosome lesions and aberrations, generally there was no
significant effect of thyroxine, at all concentrations and time periods. The most
common aberration was aneuploidy, probably because it can also occur as an
artefact during chromosome preparation. Therefore, these results are in
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accordance with our previous investigations of genotoxic effects of thyroxine
showing no effect on micronucleus induction in human peripheral blood
lymphocytes in vitro. Only the positive control (MNNG) gave a significant
(P<0.001) rise of overall aberrations, when comapred to the negative control.
Also, it should be noted that the increased frequency of chromosome aberrations
was correlated with MNNG treatment duration (Table 2).
Table 2. Cytogenetic endpoints in bone marrow cells of Swiss albino mice treated
with thyroxine for 1, 3, 7 and 10 days
Treatment Observed cytogenetic changes CA/100 cells
Negative control, 24 h 2ctg 3ane 1.25
0.1 mg/kg, 24 h 2ctg 1acf 1cf 2ane 1pol 1.75
0.5 mg/kg, 24 h 2ctg 1cf 3ane 1.50
2.5 mg/kg, 24 h 1csg 2cf 3ane 1.75
Positive control, 24 h 5ctg 2csg 9ctb 1csb 2acf 8ane 7.50***
Negative control, 3 days 1ctg 1ctb 2ane 1.00
0.1 mg/kg, 3 days 1ctg 1ctb 2ane 1pol 1.25
0.5 mg/kg, 3 days 1cf 3anea) 1.33
2.5 mg/kg, 3 days 1ctb 2cf 4ane 1.75
Positive control, 3 days 3ctg 1csg 6ctb 2csb 4acf 2cf 12ane 8.25***
Negative control, 7 days 1ctb 2ctg 3ctb 1ane 1.75
0.1 mg/kg, 7 days 2ctb 1csg 1ane 1af b) 2.00
0.5 mg/kg, 7 days 1ctb 1af 2ane 1pol 1.25
2.5 mg/kg, 7 days 1ctg 1ctb 2ane 1pol 1.25
Positive control, 7 days 10ctg 3csg 4ctb 1csb 5acf 1cf 18ane 11.50***
Negative control, 10 days 2ctg 1ctb 2ane 1.25
0.1 mg/kg, 10 days 1ctb 3ane 1.00
0.5 mg/kg, 10 days 2ctb 1af 1cf 3ane 1pol 2.00
2.5 mg/kg, 10 days 1ctb 1anec) 1.00
Positive control, 10 days 11ctg 6csg 4ctb 2csb 3af 15ane 2pold) 25.50***
CA – chromosome aberrations; ctg – chromatid gap; csg – chromosome gap; ctb – chromatid break;
csb – chromosomal break; acf – acentric fragment; cf – centric fusion; ane – aneuploidy; pol –
polyploidy
***P<0.001 (2-test)
a) one animal died on the 3rd day of treatment
b) one animal died on the 2nd day of treatment
c) one animal died on the 6th day, and one animal died on 9th day of treatment
d) two mice died on 8th and 9th day of treatment, respectively
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Finally, it has to be mentioned that animal deaths were observed. Namely,
one animal in group treated with 0.5 mg/kg of T4 for 3 days died on the third day of
treatment. Also, one animal in the group treated for 7 days died on day 2 of
treatment with 0.1 mg/kg T4, and two animals died (on days 6 and 9 respectively)
in the group treated for 10 days with 2.5 mg/kg. As for the positive control, we
observed that two mice died on the 8th and 9th day of treatment with MNNG.
DISCUSSION
There is abundant literature data about the genotoxic and mutagenic effects
of environmental pollutants (Pitarque et al. 2002; Stanimirovi} et al., 2005). Most of
the environmental genotoxins result from intense development of chemical and
other industries. Therefore, they increase in number each year. However, there is
an increasing evidence that some substances which are normally present in the
human or animal bodies may, under certain circumstances, exhibit genotoxic
effects, therefore acting as endogenous mutagenic agents (Lutz, 1990; Totsuka et
al., 2005). Probably the best studied endogenous mutagenic agents are
oestrogenic hormones (Anderson et al., 2003; Schallreuter et al., 2006).
The principal molecular mechanism of the genotoxic effects of oestrogens
comprises their metabolic conversion to catecholoestrogens and subsequent
redox cycling creating the condition of oxydative stress (Liehr, 2001; Li et al.,
2004). Interestingly, there are some experimental indices that phenolic groups of
some non-steroidal hormones (adrenaline, thyroid hormone) and
neurotransmitters (dopamine, noradrenaline) may undergo redox cycling
accompanied by generation of ROS favoring oxidative stress (Moldeus et al.,
1983; Djeli} and Anderson, 2003; Dobrzynska et al., 2004). Therefore, the
induction of oxidative stress may be the key mechanism of genotoxic effects of
both steroidal and non-steroidal hormones with phenolic groups.
There is an experimental confirmation that thyroid hormones can induce
DNA damage in human lymphocytes (Djeli} and Anderson, 2003) and sperm
(Dobrzynska et al, 2004) measured by the Comet assay. Namely, the DNA
damage measured by tail moment was significantly reduced in cells
concomitantly treated with thyroid hormone and the antioxidant enzyme catalase.
On the other hand, thyroxine induced SCEs in whole blood cultures, whereas
there was no increase in micronuclei (MN) (Djeli} et al., 2006). It is generally
acknowledged that SCE test is an indicator test of genotoxic exposure, whereas
MN test represents a mutagenicity test for detection of chromosome aberrations.
Therefore, the results of MN test should be considered of higher significance than
the results of SCE test. In previous investigations we considered that thyroxine
has not exhibited mutagenic effects in cultured human lymphocytes. Anyhow,
since the molecular mechanism(s) of SCE formation and their biological
significance remain unclear, we undertook this investigation to evaluate possible
chromosome alterations under in vivo conditions. The negative results obtained in
this in vivo investigation are in complete accordance with the absence of
mutagenic effects in the MN assay on human lymphocytes in vitro. This is quite
logical, because MN assay detects acentric fragments and/or whole
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chromosomes left behind during the nuclear division and are visible as small
additional nuclei. Moreover, our experimental results on Swiss albino mice are
particularly valuable showing that thyroxine did not induce chromosome
mutations under the in vivo conditions. Also, we monitored effects of thyroxine
during subacute treatment of up to 10 days and there was no significant change in
chromosome aberrations compared to the negative control.
Finally, our results of both in vivo and in vitro cytogenetic analysis of the
genotoxic effects of thyroxine disagree with findings that thyroid hormones
produce profound DNA damaging effects in human lymphocytes (Djeli} and
Anderson, 2003) and sperm (Dobryznska et al., 2004). This discrepancy may
have been caused because the Comet assay was performed on purified
lymphocytes. Namely, erythrocytes in whole blood cultures contain catalase and
glutathione peroxidase, which eliminate hydrogen peroxide (Andreoli et al., 1999;
Karaca et al., 2006). These antioxidant enzymes can reduce the effects of ROS
created primarily by the action of thyroid hormones on mitochondria. We also
assume that under the in vivo conditions antioxidant defence mechanisms
(Benzie, 2000) could have reduced the genotoxic effects of thyroxine. In addition,
it must be emphasised that the Comet assay has a much higher sensitivity than
standard cytogenetic analysis (Tice et al., 2000).
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EVALUACIJA GENOTOKSI^NIH EFEKATA TIROKSINA PRIMENOM IN VIVO
CITOGENETI^KOG TESTA NA SWISS ALBINO MI[EVIMA
DJELI] N, NE[I] IVANA, STANIMIROVI] Z i JOVANOVI] S
SADR@AJ
Tireoidni hormoni podsti~u aerobni metabolizam favorizuju}i oksidativni
stres koji mo`e da dovede do kovalentnih o{te}enja razli~itih molekula uklju~uju}i
i DNK. U prethodnim istra`ivanjima otkriveno je da tireoidni hormoni indukuju
o{te}enja molekula DNK u humanim limfocitima i spermi u in vitro Komet testu.
Me|utim, citogeneti~ka evaluacija genotoksi~nih efekata tiroksina dala je kontra-
diktorne rezultate: pove}anje razmena sestrinskih hromatida bez porasta u~esa-
losti mikronukleusa u kulturama humanih limfocita. Stoga je cilj istra`ivanja u
ovom radu bio da dodatno ispitamo mogu}e genotoksi~ne efekte tiroksina ko-
riste}i in vitro citogeneti~ki test na Swiss albino mi{evima.
Upotrebljene su tri eksperimentalne koncentracije tiroksina (0,1 mg/kg,
0,5 mg/kg and 2.5 mg/kg). Mi{evi su podeljeni u nekoliko grupa zavisno od
du`ine tretmana tiroksinom: 1, 3, 7 i 10 dana. U istim vremenskim periodima
mi{evi su tretirani pozitivnom (N-metil-N'-nitro-N-nitrozogvanidin) i negativnom
kontrolom. Analizirani su citogeneti~ki parametri (numeri~ke i strukturne aberacije
hromozoma, gapovi i prekidi na hromozomima) u }elijama kostne sr`i izolovanim
iz femura.
Rezultati dobijeni u ovom istra`ivanju ukazuju da tiroksin ne indukuje hro-
mozomske prekide i aberacije, {to je u saglasnosti sa na{im prethodnim zapa`a-
njima na humanim limfocitima u kulturi. Istovremeno, primetili smo smanjenje mi-
totskog indeksa, naro~ito kod `ivotinja tretiranih u du`em vremenskom periodu
sa visokim dozama tiroksina. Prema tome, mo`e se zaklju~iti da tiroksin ne indu-
kuje genotoksi~ne efekte koji mogu da se detektuju citogeneti~kim analizama.
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